Biotech · Private company
Matinas BioPharma Nanotechnologies, Inc.
Track this companyFree. Adds Matinas BioPharma Nanotechnologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Amphotericin BPhase 2 · Candidiasis, Chronic MucocutaneousClinicalTrials.gov · fetched Nov 12, 2026
- icosapent ethylPhase 2 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- Omega 3 pentaenoic acidPhase 2 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- Oral Encochleated Amphotericin B (CAMB)Phase 2 · Vulvovaginal CandidiasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With HypertriglyceridemiaPHASE2 · COMPLETED · started Jun 3, 2020ClinicalTrials.gov NCT04177680 · fetched Nov 12, 2026
- Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal CandidiasisPHASE2 · WITHDRAWN · started Dec 1, 2019ClinicalTrials.gov NCT03167957 · fetched Nov 12, 2026
- CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisPHASE2 · COMPLETED · started Sep 27, 2016ClinicalTrials.gov NCT02629419 · fetched Nov 12, 2026